Table 4 Multivariate COX regression for prognostic features of gastric cancer patients
Features | β | SE | Wald | df | P | HR (95% CI) |
|---|---|---|---|---|---|---|
T stage | ||||||
T1, T2 | − 0.916 | 0.341 | 7.229 | 1 | 0.007 | 0.400 (0.205–0.780) |
T3, T4 | ||||||
N stage | ||||||
N0 | 0.612 | 0.714 | 0.734 | 1 | 0.392 | 1.844 (0.455–7.470) |
N1–N3 | ||||||
TNM stage | ||||||
I, II | 0.703 | 0.446 | 2.485 | 1 | 0.115 | 2.019 (0.843–4.839) |
III, IV | ||||||
Tumor size | ||||||
< 5 | 0.832 | 0.494 | 2.839 | 1 | 0.092 | 2.297 (0.873–6.042) |
> 5 | ||||||
Plasma miR 106b | ||||||
Low | − 0.990 | 0.489 | 4.099 | 1 | 0.043 | 0.371 (0.142–0.969) |
High | ||||||
Plasma miR 93 | ||||||
Low | − 0.125 | 0.403 | 0.096 | 1 | 0.757 | 0.882 (0.400–1.946) |
High | ||||||
Plasma miR 25 | ||||||
Low | 0.555 | 0.407 | 1.861 | 1 | 0.172 | 1.742 (0.785–3.866) |
High | ||||||
Tumor miR 106b | ||||||
Low | 0.220 | 0.377 | 0.340 | 1 | 0.560 | 1.246 (0.595–2.612) |
High | ||||||
Tumor miR 93 | ||||||
Low | − 1.220 | 0.403 | 9.162 | 1 | 0.002 | 0.295 (0.134–0.650) |
High | ||||||
Tumor miR 25 | ||||||
Low | − 0.029 | 0.477 | 0.004 | 1 | 0.951 | 0.971 (0.381–2.473) |
High | ||||||